Application 203351
- Type
- ANDA
- Sponsor
- OHM LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SODIUM OXYBATE | SODIUM OXYBATE | SOLUTION;ORAL | 500MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| sodium oxybate | SODIUM OXYBATE | Camber Pharmaceuticals, Inc. | 5dcf9a5c-312b-420b-82f3-42177d8f9ee4 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | sodium oxybate SODIUM OXYBATE |
| sodium oxybate | SODIUM OXYBATE | XLCare Pharmaceuticals, Inc. | c0fb2620-7247-464d-a37a-8b516ce7d563 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | sodium oxybate SODIUM OXYBATE |
| Lumryz | SODIUM OXYBATE | Avadel CNS Pharmaceuticals, LLC | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | SODIUM OXYBATE |
| Xyrem | SODIUM OXYBATE | Jazz Pharmaceuticals, Inc. | 926eb076-a4a8-45e4-91ef-411f0aa4f3ca | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | SODIUM OXYBATE |
| Sodium Oxybate | SODIUM OXYBATE | Amneal Pharmaceuticals LLC | 5a9e9045-f04d-46eb-8396-2495c6090a31 | 2025-05-19 | Boxed warning, Warnings, Adverse reactions | Sodium Oxybate SODIUM OXYBATE |
| sodium oxybate | SODIUM OXYBATE | Hikma Pharmaceuticals USA Inc. | bcef2c95-35e9-464d-9025-652acff769e7 | 2023-04-25 | Boxed warning, Warnings, Adverse reactions | sodium oxybate SODIUM OXYBATE |